Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllersOlivier Lambotte, Jean‐François Delfraissy, Guido Ferrari et al.|AIDS|2009Cited by 329
HIV-1 gp41-specific monoclonal mucosal IgAs derived from highly exposed but IgG-seronegative individuals block HIV-1 epithelial transcytosis and neutralize CD4+ cell infection: an IgA gene and functional analysisDaniela Tudor, Morgane Bomsel, Muriel Derrien et al.|Mucosal Immunology|2009Cited by 140
International Network for Comparison of HIV Neutralization Assays: The NeutNet Report IILeo Heyndríckx, Gabriella Scarlatti, Alan Heath et al.|PLoS ONE|2012Cited by 138
International Network for Comparison of HIV Neutralization Assays: The NeutNet ReportÉva Mária Fenyõ, Gabriella Scarlatti, Alan Heath et al.|PLoS ONE|2009Cited by 119
A Cinnamon-Derived Procyanidin Compound Displays Anti-HIV-1 Activity by Blocking Heparan Sulfate- and Co-Receptor- Binding Sites on gp120 and Reverses T Cell Exhaustion via Impeding Tim-3 and PD-1 UpregulationBridgette J. Connell, Hugues Lortat‐Jacob, Sui‐Yuan Chang et al.|PLoS ONE|2016Cited by 42